Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers

Drug and Alcohol Dependence

Volumn 149, Issue , 2015, Pages 187-193

  Lundahl, Leslie H ^a   Greenwald, Mark K ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Cannabis dependence; Craving; Cues; Dronabinol; Marijuana; THC

Indexed keywords

CANNABIS; DRONABINOL; PLACEBO; CANNABINOID RECEPTOR AGONIST;

ADULT; ANXIETY; ARTICLE; ASSOCIATION; CANNABIS ADDICTION; CLINICAL ARTICLE; COMPULSIVITY SCALE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HEART RATE; HUMAN; HUNGER; MALE; MARIJUANA CRAVING QUESTIONNAIRE; MOOD; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; WITHDRAWAL SYNDROME; ADOLESCENT; AFFECT; BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECTS; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SEXUAL DEVELOPMENT; YOUNG ADULT;

CANNABIS; CANNABIS SATIVA;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AFFECT; ANXIETY; BLOOD PRESSURE; CANNABINOID RECEPTOR AGONISTS; CRAVING; CROSS-OVER STUDIES; CUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRONABINOL; FEMALE; HEART RATE; HUMANS; MALE; MARIJUANA ABUSE; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84926142242     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.01.046     Document Type: Article

References (73)

1. American Psychiatric Association Diagnostic and Statistical Manual Of Mental Disorders 2013, APA, Washington, DC. fifth ed.
2. Avants S.K., Margolin A., Kosten T.R., Cooney N.L. Differences between responders and nonresponders to cocaine cues in the laboratory. Addict. Behav. 1995, 20:215-224.
3. Berger S.P., Hall S., Mickalian J.D., Reid M.S., Crawford C.A., Delucchi K., Carr K., Hall S. Haloperidol antagonism of cue-elicited cocaine craving. Lancet 1996, 347:504-508.
4. Bordnick P.S., Copp H.L., Traylor A., Graap K.M., Carter B.L., Walton A., Ferrer M. Reactivity to cannabis cues in virtual reality environments. J. Psychoactive Drugs 2009, 41:105-112.
5. Budney A.J., Hughes J.R., Moore B.A., Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. Am. J. Psychiatry 2004, 161:1967-1977.
6. Budney A.J., Vandrey R.G., Hughes J.R., Moore B.A., Bahrenburg B. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. Drug Alcohol Depend. 2007, 86:22-29.
7. Budney A.J., Vandrey R.G., Hughes J.R., Thostenson J.D., Bursac Z. Comparison of cannabis and tobacco withdrawal: severity, and contribution to relapse. J. Subst. Abuse Treat. 2008, 35:362-368.
8. Calhoun S.R., Galloway G.P., Smith D.E. Abuse potential of dronabinol (Marinol). J. Psychoactive Drugs 1998, 30:187-196.
9. Carter B.L., Tiffany S.T. Meta-analysis of cue-reactivity in addiction research. Addiction 1999, 94:327-340.
10. Charboneau E.J., Dietrich M.S., Park S., Cao A., Watkins T.J., Blackford J.U., Benningfield M.M., Martin P.R., Buchowski M.S., Cowan R.L. Cannabis cue-induced brain activation correlates with drug craving in limbic and visual salience regions: preliminary results. Psychiatry Res. 2013, 214:122-131.
11. Childress A.R., McLellan A.T., Ehrman R., O'Brien C.P. Classically Conditioned Responses in Opioid and Cocaine Dependence: A Role in Relapse? Learning Factors in Substance Abuse. NIDA Res. Monogr. 1988, 94:25-43. U.S. Gov. Printing Office, Washington, DC.
12. Copeland J., Swift W., Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder. J. Subst. Abuse Treat. 2001, 20:45-52.
13. Cox L.S., Tiffany S.T., Christen A.G. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings [comment]. Nic. Tob. Res. 2001, 3:7-16.
14. Ditre J.W., Oliver J.A., Myrick H., Henderson S., Saladin M.E., Drobes D.J. Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinence. Exp. Clin. Psychopharmacol. 2012, 20:293-301.
15. Ehrman R.N., Robbins S.J., Cornish J.W., Childress A.R., O'Brien C.P. Failure of ritanserin to block cocaine cue reactivity in humans. Drug Alcohol Depend. 1996, 42:167-174.
16. Elsohly Chemical constituents of marijuana: the complex mixture of natural cannabinoids. Life Sci. 2005, 78:539-548.
17. Epstein D.H., Willner-Reid J., Vahabzadeh M., Mezghanni M., Lin J.L., Preston K.L. Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch. Gen. Psychiatry 2009, 66:88-94.
18. Field M., Duka T. Cue reactivity in smokers: the effects of perceived cigarette availability and gender. Pharmacol. Biochem. Behav. 2004, 78:647-652.
19. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis Disorders-Patient Edition (SCID-I/P, Version 2.0) 1996, APA, Washington, DC.
20. Fox H.C., Garcia M., Kemp K., Milivojevic V., Kreek M.J., Sinha R. Gender differences in cardiovascular and corticoadrenal response to stress and drug cues in cocaine dependence individuals. Psychopharmacology 2006, 185:348-357.
21. Franklin T.R., Napier K., Ehrman R., Gariti P., O'Brien C.P., Childress A.R. Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nic. Tob. Res. 2004, 6:171-175.
22. Franklin T., Wang Z., Suh J.J., Hazan R., Cruz J., Li Y., Goldman M., Detre J.A., O'Brien C.P., Childress A.R. Effects of varenicline on smoking cue-triggered neural and craving responses. Arch. Gen. Psychiatry 2011, 68:516-526.
23. Gray K.M., LaRowe S.D., Upadhyaya H.P. Cue reactivity in young marijuana smokers: a preliminary investigation. Psychol. Addict. Behav. 2008, 22:582-586.
24. Gray K.M., LaRowe S.D., Watson N.L., Carpenter M.J. Reactivity to in vivo marijuana cues among cannabis-dependent adolescents. Addict. Behav. 2011, 36:140-143.
25. Haney M. The marijuana withdrawal syndrome: diagnosis and treatment. Curr. Psychiatric Rep. 2005, 7:360-366.
26. Haney M., Hart C.L., Vosburg S.K., Nasser J., Bennert A., Zubaran C., Foltin R.W. Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 2004, 29:158-170.
27. Haney M., Hart C.L., Vosburg S.K., Comer S.D., Reed S.C., Foltin R.W. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology 2008, 197:157-168.
28. Hart C.L., Haney M., Ward A.S., Fischman M.W., Foltin R.W. Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend. 2002, 67:301-309.
29. Hart C.L., Ward A.S., Haney M., Comer S.D., Foltin R.W., Fischman M.W. Comparison of smoked marijuana and oral delta-9-tetrahydrocannabinol in humans. Psychopharmacology 2002, 164:407-415.
30. Haughey H.M., Marshall E., Schacht J.P., Louis A., Hutchison K.E. Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes. Addiction 2008, 103:1678-1686.
31. Heinz A.J., Epstein D.H., Schroeder J.R., Singleton E.G., Heishman S.J., Preston K.L. Heroin and cocaine craving and use during treatment: measurement validation and potential relationships. J. Subst. Abuse Treat. 2006, 31:355-364.
32. Heishman S.J., Singleton E.G., Liguori A. Marijuana Craving Questionnaire: development and initial validation of a self-report instrument. Addiction 2001, 96:1023-1034.
33. Hersh D., Bauer L.O., Kranzler H.R. Carbamazepine and cocaine-cue reactivity. Drug Alcohol Depend. 1995, 39:213-221.
34. Hutchison K.E., Swift R., Rohsenow D.J., Monti P.M., Davidson D., Almeida A. Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol. Psychopharmacology 2001, 155:27-34.
35. IBM Statistical Package for the Social Sciences. Version 22.0 for Mac OS X 2013, IBM Inc., Chicago, IL.
36. Jones R.T. Marihuana-induced high: influence of expectation, setting and previous drug experience. Pharmacol. Rev. 1971, 33:359-369.
37. Jorenby D.E., Hays J.T., Rigotti N.A., Azoulay S., Watsky E.J., Williams K.E., Billing C.B., Gong J., Reeves K.R. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs. placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006, 296:56-63.
38. Kranzler H.R., Bauer L.O. Bromocriptine and cocaine cue reactivity in cocaine-dependent patients. Br. J. Addict. 1992, 87:1537-1548.
39. LaRowe S.D., Myrick H., Hedden S., Mardikian P., Saladin M., McRae A., Brady K., Kalivas P.W., Malcolm R. Is cocaine desire reduced by N-acetylcysteine?. Am. J. Psychiatry 2007, 164:1115-1117.
40. Levin F.R., Mariani J.J., Brooks D.J., Pavlicova M., Cheng W., Nunes E.V. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend. 2011, 116:142-150.
41. Lowman C., Hunt W.A., Litten R.Z., Drummond D.C. Research perspectives on alcohol craving: an overview. Addiction 2000, 95(Suppl. 2):S45-S54.
42. Lundahl L.H., Johanson C.E. Cue-induced craving for marijuana in cannabis-dependent adults. Exp. Clin. Psychopharmacol. 2011, 19:223-230.
43. Marijuana Treatment Project Research Group Brief treatments for cannabis dependence: findings from a randomized multisite trial. J. Consult. Clin. Psychol. 2004, 72:455-466.
44. McRae-Clark A.L., Carter R.E., Price K.L., Baker N.L., Thomas S., Saladin M.E., Giarla K., Nicholas K., Brady K.T. Stress and cue-elicited craving and reactivity in marijuana-dependent individuals. Psychopharmacology 2011, 218:49-58.
45. Monti P.M., Binkoff J.A., Abrams D.B., Zwick W.R., Nirenberg T.D., Liepman M.R. Reactivity of alcoholics and nonalcoholics to drinking cues. J. Abnorm. Psychol. 1987, 96:122-126.
46. Niaura R.S., Rohsenow D.J., Binkoff J.A., Monti P.M., Pedraza M., Abrams D.B. Relevance of cue reactivity to understanding alcohol and smoking relapse. J. Abnorm. Psychol. 1988, 97:133-152.
47. Nickerson L.D., Ravichandran C., Lundahl L.H., Rodolico J., Dunlap S., Trksak G.H., Lukas S.E. Cue-reactivity in cannabis-dependent adolescents. Psychol. Addict. Behav. 2011, 25:168-173.
48. Nordstrom B.R., Levin F.R. Treatment of cannabis use disorders: a review of the literature. Am. J. Addict. 2007, 16:331-342.
49. O'Brien C.P., Childress A.R., Ehrman R., Robbins S.J. Conditioning factors in drug use: can they explain compulsion?. J. Psychopharmacol. 1998, 12:15-22.
50. Oslin D.W., Cary M., Slaymaker V., Colleran C., Blow F.C. Daily rating measures of alcohol craving during an inpatient stay define subtypes of alcohol addiction that predict subsequent risk for resumption of drinking. Drug Alcohol Depend. 2009, 103:131-136.
51. Paliwal P., Hyman S.M., Sinha R. Craving predicts time to cocaine relapse: further validation of the Now and Brief versions of the cocaine craving questionnaire. Drug Alcohol Depend. 2008, 93:252-259.
52. Pickens R.W., Johanson C.E. Craving: consensus of status and agenda for future research. Drug Alcohol Depend. 1992, 30:127-131.
53. Preston K.L., Vahabzadeh M., Schmittner J., Lin J.L., Gorelick D.A., Epstein D.H. Cocaine craving and use during daily life. Psychopharmacology 2009, 207:291-301.
54. Reid M.S., Thakkar V. Valproate treatment and cocaine cue reactivity in cocaine dependent individuals. Drug Alcohol Depend. 2009, 102:144-150.
55. Reid M.S., Palamar J., Raghavan S., Flammino F. Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers. Psychopharmacology 2007, 192:147-158.
56. Robbins S.J., Ehrman R.N., Childress A.R., O'Brien C.P. Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride. Addict. Behav. 1992, 17:491-499.
57. Robbins S.J., Ehrman R.N., Childress A.R., O'Brien C.P. Comparing levels of cocaine cue reactivity in male and female outpatients. Drug Alcohol Depend. 1999, 53:223-230.
58. Rohsenow D.J., Monti P.M., Hutchison K.E., Swift R.M., Colby S.M., Kaplan G.B. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J. Abnorm. Psychol. 2000, 109:738-742.
59. Rohsenow D.J., Monti P.M., Rubonis A.V., Gulliver S.B., Colby S.M., Binkoff J.A., Abrams D.B. Cue exposure with coping skills training and communication skills training for alcohol dependence: 6- and 12-month outcomes. Addiction 2001, 96:1161-1174.
60. Rohsenow D.J., Tidey J.W., Miranda R., McGeary J.E., Swift R.M., Hutchison K.E., Sirota A.D., Monti P.M. Olanzapine reduces urge to smoke and nicotine withdrawal symptoms in community smokers. Exp. Clin. Psychopharmacol. 2008, 16:215-222.
61. Sayette M.A., Shiffman S., Tiffany S.T., Niaura R.S., Martin C.S., Shadel W.G. The measurement of drug craving. Addiction 2000, 95(Suppl. 2):S189-S210.
62. Singleton E.G., Trotman A.J., Zavahir M., Taylor R.C., Heishman S.J. Determination of the reliability and validity of the Marijuana Craving Questionnaire using imagery scripts. Exp. Clin. Psychopharmacol. 2002, 10:47-53.
63. Sterling R.C., Dean J., Weinstein S.P., Murphy J., Gottheil E. Gender differences in cue exposure reactivity and 9-month outcome. J. Subst. Abuse Treat. 2004, 27:39-44.
64. Stotts A.L., Dodrill C.L., Kosten T.R. Opioid dependence treatment: options in pharmacotherapy. Expert Opin. Pharmacother. 2009, 10:1727-1740.
65. Substance Abuse and Mental Health Services Administration (SAMHSA) Center for behavioral health statistics and quality. Treatment episode data set (TEDS): 2002-2012. BHSIS Series S-71, HHS Publication No. (SMA) 14-4850 2014, Substance Abuse and Mental Health Services Administration, Rockville, MD.
66. Tiffany S.T., Drobes D.J. The development and initial validation of a questionnaire on smoking urges. Br. J. Addict. 1991, 86:1467-1476.
67. Vandrey R.G., Budney A.J., Hughes J.R., Liguori A. A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances. Drug Alcohol Depend. 2008, 92:48-54.
68. Vandrey R., Haney M. Pharmacotherapy for cannabis dependence: how close are we?. CNS Drugs 2009, 23:543-553.
69. Vandrey R., Stitzer M.L., Mintzer M.Z., Huestis M.A., Murray J.A., Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug Alcohol Depend. 2013, 128:64-70.
70. Witkiewitz K., Marlatt G.A. Relapse prevention for alcohol and drug problems: that was zen, this is tao. Am. Psychol. 2004, 59:224-235.
71. Wolfling K., Flor H., Grusser S.M. Psychophysiological responses to drug-associated stimuli in chronic heavy cannabis use. Eur. J. Neurosci. 2008, 27:976-983.
72. Yu J., Zhang S., Epstein D.H., Fang Y., Shi J., Qin H., Yao S., Le Foll B., Lu L. Gender and stimulus effects in cue-induced responses in abstinent heroin users. Pharmacol. Biochem. Behav. 2007, 86:485-492.
73. Zachary R.A. Shipley Institute of Living Scale: Revised Manual 1986, Western Psychological Services, Los Angeles, CA.